Lipidor publishes annual report for 2020

Stockholm, Sweden, 23 April 2021 – Lipidor AB (publ) (Nasdaq First North: LIPI) today announces that the company will publish its annual report for the financial year 2020. The annual report (in Swedish) is available on the company’s website lipidor.se and in the attached pdf.

The information was submitted for publication, through the office of the contact person, on 23 April 2021, at 12.00pm CEST.

For more information, please contact:

Ola Holmlund, CEO
Telephone: +46 (0)72 50 70 369
Email: ola.holmlund@lipidor.se

Certified Adviser

Erik Penser Bank AB
Telephone: +46 (0)8 463 80 00
E-mail: certifiedadviser@penser.se

About Lipidor AB

Lipidor AB (www.lipidor.se) is a Swedish, Stockholm-based research and development company with a pipeline of pharmaceutical development projects in preclinical and clinical phases. The Company develops topical medical products for the treatment of diseases such as psoriasis, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.